Junran Zhang

5.2k total citations · 1 hit paper
71 papers, 3.9k citations indexed

About

Junran Zhang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Junran Zhang has authored 71 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 28 papers in Oncology and 8 papers in Genetics. Recurrent topics in Junran Zhang's work include DNA Repair Mechanisms (30 papers), PARP inhibition in cancer therapy (13 papers) and CRISPR and Genetic Engineering (11 papers). Junran Zhang is often cited by papers focused on DNA Repair Mechanisms (30 papers), PARP inhibition in cancer therapy (13 papers) and CRISPR and Genetic Engineering (11 papers). Junran Zhang collaborates with scholars based in United States, China and India. Junran Zhang's co-authors include Simon N. Powell, Zhihui Feng, Zhaojun Qiu, Chunhong Yan, Nancy L. Oleinick, Han‐Fei Ding, Hongbo Wang, Mengqi Guo, Zhefu Ma and Tingting Du and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Junran Zhang

68 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–

2019 611 citations Junran Zhang, Chunhong Yan et al. profile →

Peers

Countries citing papers authored by Junran Zhang

Since Specialization

Citations

This map shows the geographic impact of Junran Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junran Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junran Zhang more than expected).

Fields of papers citing papers by Junran Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junran Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junran Zhang. The network helps show where Junran Zhang may publish in the future.

Co-authorship network of co-authors of Junran Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Junran Zhang. A scholar is included among the top collaborators of Junran Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junran Zhang. Junran Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition 2026 ·Science Translational Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Na Li, (unknown), (unknown), (unknown), (unknown), Yongchen Guo, Masha V. Poyurovsky, (unknown), Junran Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation 2025 ·Journal of Clinical Investigation ·Zhaojun Qiu, (unknown), Anqi Li, Deepika Singh, (unknown), Chunhong Yan, David P. Carbone, Qi-En Wang, Xiaoli Zhang, Zihai Li, Junran Zhang	0
3	Materials design and preparation of ultrathin two-dimensional metal halide perovskites 2024 ·Nano Research ·Xiaomin Zhang, Sihan Zhao, Junran Zhang, Lin Wang	2
4	Low PPP2R2A expression promotes sensitivity to CHK1 inhibition in high-grade serous ovarian cancer 2024 ·Theranostics ·Zhaojun Qiu, (unknown), Yujie Liu, (unknown), Nigel Bean, Chunhong Yan, Zaibo Li, Xiaoli Zhang, Goutham Narla, Analisa DiFeo, Qi-En Wang, Junran Zhang	1
5	The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity 2024 ·Nature Communications ·(unknown), Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li, Deepika Singh, (unknown), Young‐Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Qi‐En Wang, Deliang Guo, Baek Kim, Junran Zhang	6
6	Excessive Iodine Enabled Ultrathin Inorganic Perovskite Growth at the Liquid‐Air Interface 2023 ·Angewandte Chemie International Edition ·(unknown), Xiaomin Zhang, Dawei Zhou, (unknown), (unknown), Sihan Zhao, (unknown), (unknown), Xu Zhang, (unknown), Jin Tang, (unknown), Junran Zhang, Chao Zhu, Ti Wang, Longfei Ruan, Chongqin Zhu, Xuefen Song, Wei Huang, Lin Wang	6
7	Dynamic and Wearable Electro-responsive Hydrogel with Robust Mechanical Properties for Drug Release 2023 ·ACS Applied Materials & Interfaces ·Xiaozhuang Zhou, Nan Zhang, (unknown), Huapeng Li, (unknown), Shiqi Zhang, Jiangjiang Zhu, Junran Zhang, Jiaxi Cui, Qingfei Zheng	24
8	Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research 2023 ·Cells ·(unknown), (unknown), Zaibo Li, Xiaokui Mo, (unknown), Bhaskar Kallakury, Richard Schlegel, Junran Zhang, Deliang Guo, Priscilla A. Furth, Xuefeng Liu, Jenny Li	3
9	AIB1 is a novel target of the high‐risk HPV E6 protein and a biomarker of cervical cancer progression 2022 ·Journal of Medical Virology ·(unknown), Aleksandra Dakic, Megan E. Spurgeon, (unknown), Bhaskar Kallakury, Bo Zhao, Junran Zhang, Jian Zhu, Qin Ma, Ying Xu, Paul F. Lambert, Richard Schlegel, Anna T. Riegel, Xuefeng Liu	7
10	Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment 2022 ·JCI Insight ·(unknown), Dongdong Liang, (unknown), (unknown), Caitlin Lynch, Srilatha Sakamuru, Scott Heyward, Junran Zhang, (unknown), Young Wook Chun, Ruili Huang, Menghang Xia, Charles C. Hong, Fengtian Xue, Hongbing Wang	6
11	A Novel Role for RNF126 in the Promotion of G2 Arrest via Interaction With 14-3-3σ 2021 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Zhaojun Qiu, Qi‐En Wang, Chunhong Yan, Junran Zhang	4
12	A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors 2020 ·Cancer Research ·Zhaojun Qiu, (unknown), Tao Liu, (unknown), (unknown), (unknown), E. Ricky Chan, (unknown), Zaibo Li, Kai He, Qi‐En Wang, Terence M. Williams, Chunhong Yan, Steven T. Sizemore, Goutham Narla, Junran Zhang	26
13	Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy 2020 ·Clinical Cancer Research ·Linlin Yang, Changxian Shen, (unknown), Tianyun Li, (unknown), Eric D. Miller, Junran Zhang, Steven H. Lin, Terence M. Williams	38
14	ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2−/− Ovarian Cancer Cells 2019 ·Molecular Cancer Therapeutics ·Lu Liu, Shurui Cai, Chunhua Han, Ananya Banerjee, Dayong Wu, (unknown), (unknown), Junran Zhang, Xiaoli Zhang, Eric McLaughlin, Ming Yin, Floor Backes, Arnab Chakravarti, Yanfang Zheng, Qi‐En Wang	51
15	RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells 2018 ·Clinical Cancer Research ·Xiaosong Yang, Pan You, Zhaojun Qiu, Zhanwen Du, Yao Zhang, (unknown), Shashank Gorityala, (unknown), Shunqiang Li, Ceshi Chen, (unknown), Yan Xu, Chunhong Yan, (unknown), Zhefu Ma, Junran Zhang	30
16	Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment 2016 ·Molecular Cancer Therapeutics ·William D. Hedrich, Jingwei Xiao, Scott Heyward, (unknown), Junran Zhang, Maria R. Baer, (unknown), Hongbing Wang	17
17	Altered effective connectivity of posterior thalamus in migraine with cutaneous allodynia: a resting-state fMRI study with granger causality analysis 2016 ·The Journal of Headache and Pain ·Ting Wang, Ning Chen, Zhan Wang, Jia Liu, Junpeng Zhang, Qi Liu, Hua Huang, Li He, Junran Zhang, Qiyong Gong	44
18	The TMPRSS2–ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition 2015 ·Molecular Cancer Therapeutics ·Payel Chatterjee, Gaurav S. Choudhary, (unknown), (unknown), Warren D.W. Heston, Cristina Magi‐Galluzzi, Junran Zhang, Eric A. Klein, Alexandru Almasan	30
19	The Polyamine Catabolic Enzyme SAT1 Modulates Tumorigenesis and Radiation Response in GBM 2014 ·Cancer Research ·Adina Brett-Morris, (unknown), Yuji Seo, Vinay Pasupuleti, Junran Zhang, Jun Lu, Raffaella Spina, Eli E. Bar, Maneesh Gujrati, Rebecca M. Schur, Zheng‐Rong Lu, Scott M. Welford	47
20	Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis 2006 ·Molecular and Cellular Biology ·Zhefu Ma, Shannon L. Gibson, (unknown), Junran Zhang, Morris F. White, (unknown)	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact